chemotherapy

Research Reports

Factors Associated With Poor Outcomes in Patients who Receive Cancer Directed Therapy at the End of Life

02/15/2022

Yasmine Anouty, PharmD

Ila M. Saunders, PharmD, BCOP

Shanna Block, PharmD, BCOP

Katherine Medley, PharmD

Rabia S. Atayee, PharmD, BCPS

Megan Wall, MS

Alison Wall, MS

Carolyn Mulroney, MD

Janine Martino, PharmD, BCOP, APh

Yasmine Anouty, PharmD, and colleagues discern factors that may be associated with poor outcomes in adult patients who received intravenous cancer-directed therapy in the last 30 days of life.

Yasmine Anouty, PharmD, and...

02/15/2022

Journal of Clinical Pathways

From the Field

Referral Patterns and Treatment Preferences in Patients With Advanced Prostate Cancer: Differences Between Medical Oncologists and Urologists

10/20/2021

Ajeet Gajra, MD, FACP

Skyler Hime Rupard, MS

Yolaine Jeune-Smith, PhD

Bruce Feinberg, DO

Ajeet Gajra, MD, FACP, et al assessed the differences between medical oncologists and urologists regarding perceptions on timing of referral and treatment sequence decisions for patients with advanced prostate cancer

Ajeet Gajra, MD, FACP, et al...

10/20/2021

Journal of Clinical Pathways

Research Reports

Costs of Care for Patients Receiving Chemotherapy for Advanced Bladder Cancer

12/13/2017

Ashish M Kamat, MD, MBBS

Xiting Cao, PhD

Jinghua He, PhD, MPH

Yichen Zhong, MPH

Amishi Y Shah, MD

Kyle Flannery, PharmD, MS